Work

Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study

Year: 2021

Type: article

Study design: Clinical Trial

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-021-06266-9

Authors: M. L. Lopresti, J. J. Bian, B. J. Sakr, R. S. Strenger, R. D. Legare, M. Fenton, S. M. Witherby, D. S. Dizon, S. V. Pandya, A. R. Stuckey, D. A. Edmondson, J. S. Gass, C. M. Emmick, T. A. Graves, M. Cutitar, A. J. Olszewski, W. M. Sikov

Institutions: Brown University, Lifespan, Maine Medical Center, Maine Medical Center, Women & Infants Hospital of Rhode Island, Beth Israel Deaconess Medical Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: Brown University

OpenAlex ID: W3136458548

FWCI: 0.182

Cites: 17

Cited by: 5

Related to: 10